Azafaros completes EUR25m Series A financing to advance rare metabolic disorders pipeline
This round was led by Forbion, with participation from BioMedPartners and founding investor BioGeneration Ventures (BGV). Azafaros was established in 2018 to translate innovative science from Leiden University